Company Performance Metrics
- Robert Nicol: Co-Founder
- Jeff He: Chief Operating OfficerPast Role: Harbour Biomed, Co-Founder & CFO
HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires to benefit patients through open-innovation partnerships with industry and academia. HiFiBiO integrates deep-rooted
biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders.
The company was founded in 2013 and is headquartered in Paris, Ille-de-France.